Found: 2
Select item for more details and to access through your institution.
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1825, doi. 10.3390/cancers16101825
- By:
- Publication type:
- Article
Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245296
- By:
- Publication type:
- Article